Filing Details

Accession Number:
0000908662-13-000160
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-28 16:25:05
Reporting Period:
2013-03-26
Filing Date:
2013-03-28
Accepted Time:
2013-03-28 16:25:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1177648 Enanta Pharmaceuticals Inc ENTA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1572282 Terry Vance C/O Enanta Pharmaceuticals, Inc.
500 Arsenal Street
Watertown MA 02472
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-03-26 13,295 $14.00 13,295 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct